Amgen, Pfizer Will No Longer Co-Market Enbrel
April 19, 2012
Amgen and Pfizer will end co-promotion of Enbrel (etanercept) in North America this summer, the companies tell the Wall Street Journal. Amgen will assume full marketing responsibilities in the US, effective July 23.
Facebook Comments